Astrazeneca

FromAstraZeneca ([email protected])
Subject (49)Datroway approved in US for 1L triple-negative BC
Preheader (149)Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast
Typography
Arial
Colors
Text Analysis
Body Words144
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px742 px
X-Spam Score1.6
Preheader OptimizedNo
Timing
Day of WeekMonday
TimeAfternoon

Datroway approved in US for 1L triple-negative BC

Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast
Datroway approved in US for 1L triple-negative BC